Risk of coronary artery disease in individuals infected with human immunodeficiency virus

Article English OPEN
Felippe Dantas Vilela ; Andrea Rocha de Lorenzo ; Bernardo Rangel Tura ; Giovanna Ianini Ferraiuoli ; Marcelo Hadlich ; Marcelo Viana de Lima Barros ; Ana Beatriz Ribeiro Lima ; Vanderson Meirelles
  • Publisher: Elsevier
  • Journal: Brazilian Journal of Infectious Diseases, volume 15, issue 6, pages 521-527 (issn: 1678-4391)
  • Related identifiers: doi: 10.1590/S1413-86702011000600004, doi: 10.1016/s1413-8670(11)70245-8
  • Subject: coronary artery disease | HIV protease inhibitors | RC109-216 | HIV | Infectious and parasitic diseases | Medicine(all) | cardiovascular diseases

Current treatment for human immunodeficiency virus (HIV) infection has improved survival and allowed infected patients to develop atherosclerotic coronary artery disease (CAD). Specific strategies to reduce cardiovascular risk in the infected population have not been de... View more
Share - Bookmark